开云app官网登录入口网页版-官方正版

#肝病患者#

84篇内容 | 1876人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2017998, encodeId=07aa201e998ab, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Dig Dis Sci: 晚期慢性肝病患者肝静脉压力梯度≤10mmHg与临床结果相关, objectType=article, longId=299631, objectId=e39a29963192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e39a29963192, replyNumber=0, likeNumber=75, createdTime=2022-08-07, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e39a29963192, moduleTitle=Dig Dis Sci: 晚期慢性肝病患者肝静脉压力梯度≤10mmHg与临床结果相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e39a29963192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017997, encodeId=5b9b201e99751, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=American Journal of Gastroenterology：非糖尿病成人的空腹酮尿与非酒精性脂肪肝病患者肝纤维化的风险, objectType=article, longId=219992, objectId=de6f21999268, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de6f21999268, replyNumber=0, likeNumber=68, createdTime=2022-10-04, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de6f21999268, moduleTitle=American Journal of Gastroenterology：非糖尿病成人的空腹酮尿与非酒精性脂肪肝病患者肝纤维化的风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=de6f21999268)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017990, encodeId=5852201e9904f, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Gut：非酒精性脂肪性肝病患者的胃肠道癌症风险增加高达2倍！, objectType=article, longId=208278, objectId=665b2082e84a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=665b2082e84a, replyNumber=0, likeNumber=65, createdTime=2022-01-20, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=665b2082e84a, moduleTitle=Gut：非酒精性脂肪性肝病患者的胃肠道癌症风险增加高达2倍！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=665b2082e84a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017995, encodeId=5a7d201e99506, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=GUT：β受体阻滞剂通过改善晚期慢性肝病患者全身炎症从而改善临床结果, objectType=article, longId=216275, objectId=869f2162e50f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=869f2162e50f, replyNumber=0, likeNumber=61, createdTime=2021-12-15, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=869f2162e50f, moduleTitle=GUT：β受体阻滞剂通过改善晚期慢性肝病患者全身炎症从而改善临床结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=869f2162e50f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017996, encodeId=9194201e996c3, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Nature：慢性肝病患者细胞存在频繁的趋同进化, objectType=article, longId=218603, objectId=2b43218603e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b43218603e1, replyNumber=0, likeNumber=79, createdTime=2021-10-30, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b43218603e1, moduleTitle=Nature：慢性肝病患者细胞存在频繁的趋同进化, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2b43218603e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017992, encodeId=f986201e9922c, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Radiology：无创影像学检测手段，慢性肝病患者的又一选择！, objectType=article, longId=211047, objectId=120521104efd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=120521104efd, replyNumber=0, likeNumber=58, createdTime=2022-04-10, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=120521104efd, moduleTitle=Radiology：无创影像学检测手段，慢性肝病患者的又一选择！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=120521104efd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017989, encodeId=b855201e98970, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Am J Gastroenterol：异体粪便微生物移植可改善非酒精性脂肪性肝病患者异常的小肠通透性, objectType=article, longId=204311, objectId=e78920431155, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e78920431155, replyNumber=0, likeNumber=85, createdTime=2021-05-06, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e78920431155, moduleTitle=Am J Gastroenterol：异体粪便微生物移植可改善非酒精性脂肪性肝病患者异常的小肠通透性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e78920431155)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017994, encodeId=55bb201e994eb, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=JAMA Surg：禁酒6个月 vs 提前肝移植对酒精相关肝病患者预后的影响, objectType=article, longId=215926, objectId=9d2621592605, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d2621592605, replyNumber=0, likeNumber=62, createdTime=2022-04-11, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d2621592605, moduleTitle=JAMA Surg：禁酒6个月 vs 提前肝移植对酒精相关肝病患者预后的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9d2621592605)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017993, encodeId=7468201e9934d, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Radiology：钆塞酸二钠增强MRI能预测慢性肝病患者的预后吗？, objectType=article, longId=212386, objectId=21e6212386a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21e6212386a7, replyNumber=0, likeNumber=85, createdTime=2021-09-12, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21e6212386a7, moduleTitle=Radiology：钆塞酸二钠增强MRI能预测慢性肝病患者的预后吗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=21e6212386a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017986, encodeId=432f201e986f4, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性, objectType=article, longId=199610, objectId=27e819961026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27e819961026, replyNumber=0, likeNumber=69, createdTime=2021-03-13, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27e819961026, moduleTitle=Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=27e819961026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017991, encodeId=c197201e99140, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=慢性肝病患者肝纤维化FIB-4指数, objectType=article, longId=209856, objectId=e771209856c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e771209856c7, replyNumber=0, likeNumber=73, createdTime=2021-06-25, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e771209856c7, moduleTitle=慢性肝病患者肝纤维化FIB-4指数, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e771209856c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017983, encodeId=9708201e983cb, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Radiology：晚期慢性肝病患者不进行肝移植会怎样？, objectType=article, longId=194772, objectId=1e83194e7204, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e83194e7204, replyNumber=0, likeNumber=63, createdTime=2020-09-02, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e83194e7204, moduleTitle=Radiology：晚期慢性肝病患者不进行肝移植会怎样？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1e83194e7204)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017985, encodeId=6d87201e98569, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=J Hepatol：侯金林教授团队发表全球跨病因和跨种族的慢性肝病患者肝癌风险预测模型——aMAP评分, objectType=article, longId=199324, objectId=7ddb1993246a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ddb1993246a, replyNumber=0, likeNumber=88, createdTime=2020-12-01, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ddb1993246a, moduleTitle=J Hepatol：侯金林教授团队发表全球跨病因和跨种族的慢性肝病患者肝癌风险预测模型——aMAP评分, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7ddb1993246a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017987, encodeId=b694201e9873d, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=J Hepatol: Maddrey评分<32分且病理提示存在脂肪性肝炎的酒精性肝病患者长期预后特点, objectType=article, longId=199716, objectId=2d7d199e16c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d7d199e16c8, replyNumber=0, likeNumber=68, createdTime=2021-01-21, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d7d199e16c8, moduleTitle=J Hepatol: Maddrey评分<32分且病理提示存在脂肪性肝炎的酒精性肝病患者长期预后特点, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2d7d199e16c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017981, encodeId=d439201e98167, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=中国NMPA批准针对成年慢性肝病患者的血小板减少症药物——血小板生成素激动剂DOPTELET, objectType=article, longId=193385, objectId=69891933853e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69891933853e, replyNumber=0, likeNumber=73, createdTime=2020-11-12, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69891933853e, moduleTitle=中国NMPA批准针对成年慢性肝病患者的血小板减少症药物——血小板生成素激动剂DOPTELET, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=69891933853e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017978, encodeId=ccbb201e978c0, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=CLIN CHEM LAB MED：Copeptin 作为晚期肝病患者短期死亡风险的生物标志物？, objectType=article, longId=187086, objectId=f71818e0869c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f71818e0869c, replyNumber=0, likeNumber=65, createdTime=2020-09-13, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f71818e0869c, moduleTitle=CLIN CHEM LAB MED：Copeptin 作为晚期肝病患者短期死亡风险的生物标志物？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f71818e0869c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017984, encodeId=6f4a201e984e2, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Gastroenterology：肠道微生物和脂质代谢产物是肝病患者慢性肠道功能衰竭和死亡的独立危险因素, objectType=article, longId=197751, objectId=992319e75184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=992319e75184, replyNumber=0, likeNumber=84, createdTime=2020-08-03, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=992319e75184, moduleTitle=Gastroenterology：肠道微生物和脂质代谢产物是肝病患者慢性肠道功能衰竭和死亡的独立危险因素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=992319e75184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017988, encodeId=05b3201e98897, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=World J Gastroenterology：高尔基蛋白73：一种评估肝病患者肝硬化和预后的生物标志物, objectType=article, longId=200892, objectId=09652008920f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09652008920f, replyNumber=0, likeNumber=74, createdTime=2020-09-25, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09652008920f, moduleTitle=World J Gastroenterology：高尔基蛋白73：一种评估肝病患者肝硬化和预后的生物标志物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=09652008920f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017979, encodeId=2e98201e979d7, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=AP&T：二甲双胍在慢性肝病患者中的安全性和药代动力学, objectType=article, longId=188221, objectId=2cdc188221b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cdc188221b6, replyNumber=0, likeNumber=66, createdTime=2020-07-29, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cdc188221b6, moduleTitle=AP&T：二甲双胍在慢性肝病患者中的安全性和药代动力学, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2cdc188221b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017982, encodeId=8087201e982e6, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Gastroenterology：合生元可改变非酒精性脂肪性肝病患者的粪便微生物群但不改变肝脏脂肪或纤维化 , objectType=article, longId=193492, objectId=d99219349250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d99219349250, replyNumber=0, likeNumber=90, createdTime=2021-01-04, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d99219349250, moduleTitle=Gastroenterology：合生元可改变非酒精性脂肪性肝病患者的粪便微生物群但不改变肝脏脂肪或纤维化 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d99219349250)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

肝病患者

2020-05-29

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Dig Dis Sci: 晚期慢性肝病患者肝静脉压力梯度≤10mmHg与临床结果相关

2022-08-07

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

American Journal of Gastroenterology：非糖尿病成人的空腹酮尿与非酒精性脂肪肝病患者肝纤维化的风险

2022-10-04

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Gut：非酒精性脂肪性肝病患者的胃肠道癌症风险增加高达2倍！

2022-01-20

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

GUT：β受体阻滞剂通过改善晚期慢性肝病患者全身炎症从而改善临床结果

2021-12-15

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Nature：慢性肝病患者细胞存在频繁的趋同进化

2021-10-30

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Radiology：无创影像学检测手段，慢性肝病患者的又一选择！

2022-04-10

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Am J Gastroenterol：异体粪便微生物移植可改善非酒精性脂肪性肝病患者异常的小肠通透性

2021-05-06

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

JAMA Surg：禁酒6个月 vs 提前肝移植对酒精相关肝病患者预后的影响

2022-04-11

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Radiology：钆塞酸二钠增强MRI能预测慢性肝病患者的预后吗？

2021-09-12

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性

2021-03-13

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

慢性肝病患者肝纤维化FIB-4指数

2021-06-25

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Radiology：晚期慢性肝病患者不进行肝移植会怎样？

2020-09-02

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

J Hepatol：侯金林教授团队发表全球跨病因和跨种族的慢性肝病患者肝癌风险预测模型——aMAP评分

2020-12-01

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

J Hepatol: Maddrey评分<32分且病理提示存在脂肪性肝炎的酒精性肝病患者长期预后特点

2021-01-21

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

中国NMPA批准针对成年慢性肝病患者的血小板减少症药物——血小板生成素激动剂DOPTELET

2020-11-12

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

CLIN CHEM LAB MED：Copeptin 作为晚期肝病患者短期死亡风险的生物标志物？

2020-09-13

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Gastroenterology：肠道微生物和脂质代谢产物是肝病患者慢性肠道功能衰竭和死亡的独立危险因素

2020-08-03

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

World J Gastroenterology：高尔基蛋白73：一种评估肝病患者肝硬化和预后的生物标志物

2020-09-25

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

AP&T：二甲双胍在慢性肝病患者中的安全性和药代动力学

2020-07-29

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Gastroenterology：合生元可改变非酒精性脂肪性肝病患者的粪便微生物群但不改变肝脏脂肪或纤维化

2021-01-04

科室
- - 订阅+
  - 更多科室
工具
服务